Madrid, Spain

Cristian Fernandez

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Pharma Mar, S.a.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cristian Fernandez. Retrieved from https://idiyas.com/inventor/cristian-fernandez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Cristian Fernandez: Innovator in Cancer Treatment

Introduction

Cristian Fernandez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of cancer treatment, particularly through his work with the pharmaceutical company Pharma Mar, S.A. His innovative approaches have led to the development of several patents aimed at improving patient outcomes in oncology.

Latest Patents

Cristian Fernandez holds 4 patents that focus on the treatment of small cell lung cancer (SCLC). His latest patents include a method of treating SCLC and managing thrombocytopenia. This invention provides methods for treating SCLC patients by administering therapeutic amounts of lurbinectedin via intravenous infusion. It also explores the combination of lurbinectedin with other anticancer drugs, particularly topoisomerase inhibitors. Additionally, the invention addresses the administration of lurbinectedin alongside anti-emetic agents to effectively control symptoms related to nausea and vomiting. It emphasizes reduced dosages of lurbinectedin for safer administration and an increase in the number of treatment cycles. Furthermore, stable lyophilized formulations of lurbinectedin are also included in this patent.

Another significant patent by Fernandez is a method of treating SCLC and managing neutropenia. Similar to his previous patent, it involves administering therapeutic amounts of lurbinectedin by intravenous infusion and explores its combination with other anticancer drugs. This invention also focuses on the administration of lurbinectedin with anti-emetic agents for better symptom management and safety.

Career Highlights

Cristian Fernandez has established himself as a key figure in the pharmaceutical industry, particularly in the realm of cancer research and treatment. His work at Pharma Mar, S.A. has been instrumental in advancing therapeutic options for patients suffering from SCLC. His innovative methods and formulations have the potential to significantly improve treatment efficacy and patient quality of life.

Collaborations

Throughout his career, Cristian has collaborated with notable colleagues, including Carmen Kahatt and José María Fernandez. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of better cancer treatments.

Conclusion

Cristian Fernandez is a pioneering inventor whose work in cancer treatment has led to the development of valuable patents that enhance patient care. His contributions to the field continue to inspire advancements in oncology and improve the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…